YC S14Inactive

Bikanta

Nano-diamonds for cancer detection

About

Bikanta is introducing revolutionary nanodiamond-based technology to push the boundaries of current medical imaging and diagnostics, allowing researchers to answer questions and medics to detect diseases that they currently cannot. A nanodiamond is forever. They are brightly fluorescent, infinitely stable, non-toxic, functionalizable and can be used for background-free optical imaging. Early results have improved the signal by as much as 100-fold over conventional fluorescence imaging techniques. Bikanta’s vision is to redefine the boundaries of medical diagnostics by delivering cutting-edge imaging probes and background-free optical imaging.

Founder

Family Office Investors

Altss tracks family office allocations to YC-backed companies. Request access to see which family offices have invested in Bikanta.

See family office activity

Industry & Focus

HealthcareDiagnosticsNanomedicine